
Description Mansoor Mohammed, Ph.D. has served as the Chief Executive Officer of our wholly owned subsidiary CombiMatrix Molecular Diagnostics, Inc. (CMDX) since February 2007. Previously, he served as the Chief Scientific Officer of CMDX from March 2006 to April 2006 and as the President and Chief Operating Officer of CMDX from April 2006 to February 2007. Dr. Mohammed is a recognized leader in genome and microarray technologies and is a frequent keynote speaker both nationally and internationally. Dr. Mohammed received his Ph.D. in molecular immunology and molecular genetics from the University of Guelph, Canada. He completed postdoctoral training at the University of California, Los Angeles, first in the department of molecular immunology and genetics and then as a clinical fellow in cytogenetics. Dr. Mohammed then continued his clinical cytogenetics training at Baylor College of Medicine, Houston and was appointed Director of Research and Development at Spectral Genomics Inc., where he helped pioneer the first commercially available whole genome BAC array. From September 2003 to February 2006, Dr. Mohammed served as Director of the Department of Advanced Technologies at Quest Diagnostics Incorporated. He is the holder of multiple patents in the fields of molecular immunology and genomic microarray technologies. In addition to his role at CMDX, Dr. Mohammed serves as an ambassador of sciences to the Toronto Genome Center. To view the detailed information, you need to SUBSCRIBE with us. |
![]() |